Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells

被引:51
作者
Champney, WS [1 ]
Burdine, R [1 ]
机构
[1] E Tennessee State Univ, Quillen Dishner Coll Med, Dept Biochem & Mol Biol, Johnson City, TN 37614 USA
关键词
D O I
10.1007/s002849900290
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ID50 values for azithromycin and clarithromycin inhibition of translation and of 50S assembly in Staphylococcus aureus cells have been measured. For clarithromycin, 50% inhibition of growth occurred at 0.075 mu g/ml, and the effects on translation and 50S formation were equivalent at 0.15 mu g/ml. The inhibition of these processes by azithromycin was less effective, with an ID50 of 2.5 mu g/ml for growth and 5 mu g/ml for inhibition of translation and 50S formation, The additive effects of each of these drugs on translation and 50S formation account quantitatively for their observed influence on cellular growth rates, In macrolide-treated cells, there was also a direct relationship between the loss of ribosomal RNA from the 50S subunit and its accumulation as oligoribonucleotides. These results are compared with the previously described effects of erythromycin on these same processes.
引用
收藏
页码:119 / 123
页数:5
相关论文
共 11 条
[1]   RELATIVE POTENCIES OF AZITHROMYCIN, CLARITHROMYCIN AND 5 OTHER ORALLY-ADMINISTERED ANTIBIOTICS [J].
BARRY, AL ;
FUCHS, PC ;
BROWN, SD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (04) :552-555
[2]   50S ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus [J].
Champney, WS ;
Burdine, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1301-1303
[3]   MACROLIDE ANTIBIOTICS INHIBIT 50S RIBOSOMAL-SUBUNIT ASSEMBLY IN BACILLUS-SUBTILIS AND STAPHYLOCOCCUS-AUREUS [J].
CHAMPNEY, WS ;
BURDINE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) :2141-2144
[4]   ERYTHROMYCIN INHIBITS THE ASSEMBLY OF THE LARGE RIBOSOMAL-SUBUNIT IN GROWING ESCHERICHIA-COLI-CELLS [J].
CHITTUM, HS ;
CHAMPNEY, WS .
CURRENT MICROBIOLOGY, 1995, 30 (05) :273-279
[5]   ERYTHROMYCIN, CLARITHROMYCIN, AND AZITHROMYCIN - USE OF FREQUENCY-DISTRIBUTION CURVES, SCATTERGRAMS, AND REGRESSION-ANALYSES TO COMPARE IN-VITRO ACTIVITIES AND DESCRIBE CROSS-RESISTANCE [J].
FASS, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) :2080-2086
[6]   COMPARATIVE INVITRO ACTIVITIES OF NEW 14-MEMBERED, 15-MEMBERED, AND 16-MEMBERED MACROLIDES [J].
HARDY, DJ ;
HENSEY, DM ;
BEYER, JM ;
VOJTKO, C ;
MCDONALD, EJ ;
FERNANDES, PB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1710-1719
[7]  
Kirst H A, 1993, Prog Med Chem, V30, P57, DOI 10.1016/S0079-6468(08)70375-8
[8]  
MAZZEI T, 1993, J ANTIMICROB CHEMOTH, V31, P1
[9]  
WHITMAN MS, 1992, INFECT CONT HOSP EP, V13, P357
[10]   COMPARISON OF MACROLIDE ANTIBIOTICS [J].
WILLIAMS, JD ;
SEFTON, AM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 :11-26